CHAPTER 1: INTRODUCTION

1.1. Report Description
1.2. Key Benefits For Stakeholders
1.3. Key Market Segments
1.4. Research Methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market Definition And Scope
3.2. Key Findings

3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.2.3. Top Winning Strategies, By Year, 2014-2017*
3.2.4. Top Winning Strategies, By Development, 2014-2017* (%)
3.2.5. Top Winning Strategies, By Company, 2014-2017*

3.3. Porters Five Forces Analysis
3.4. Top Player Positioning
3.5. Market Dynamics

3.5.1. Drivers

3.5.1.1. Growth in geriatric population
3.5.1.2. Increasing technological advancements and rising amniotic membrane transplantations
3.5.1.3. Increased awareness to reduce healthcare costs

3.5.2. Restraints

3.5.2.1. Dearth of skilled professionals

3.5.3. Opportunities

3.5.3.1. Increasing awareness about the advantages of amniotic membrane transplant

CHAPTER 4: AMNIOTIC MEMBRANE MARKET BY PRODUCT

4.1. Overview
4.2. Market Size and Forecast
4.3. Cryopreserved Amniotic Membrane

4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast by region

4.4. Lyophilization Amniotic Membrane

4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast by region

CHAPTER 5: AMNIOTIC MEMBRANE MARKET BY APPLICATION

5.1. Overview

5.1.1. Market size and forecast

5.2. Surgical Wounds

5.2.1. Market size and forecast by region

5.3. Ophthalmology

5.3.1. Market size and forecast by region

5.4. Others

5.4.1. Market size and forecast by region

CHAPTER 6: AMNIOTIC MEMBRANE MARKET BY END-USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals

6.2.1. Market size and forecast by region

6.3. Ambulatory Surgical Centers

6.3.1. Market size and forecast by region

6.4. Specialized Clinics

6.4.1. Market size and forecast by region

6.5. Research Centers & Laboratory

6.5.1. Market size and forecast by region

CHAPTER 7: AMNIOTIC MEMBRANE MARKET, BY REGION

7.1. Overview

7.1.1. Market size and forecast

7.2. North America

7.2.1. North America Market size and forecast by country
7.2.2. North America Market size and forecast by Product
7.2.3. North America Market size and forecast by Application
7.2.4. North America Market size and forecast by End User

7.2.1.1. U.S. Market size and forecast by product
7.2.1.2. U.S. Market size and forecast by application
7.2.1.3. U.S. Market size and forecast by end user
7.2.1.4. Canada Market size and forecast by product
7.2.1.5. Canada Market size and forecast by application
7.2.1.6. Canada Market size and forecast by end user
7.2.1.7. Mexico Market size and forecast by product
7.2.1.8. Mexico Market size and forecast by application
7.2.1.9. Mexico Market size and forecast by end user

7.3. Europe

7.3.1. Europe Market size and forecast by product
7.3.1. Europe Market size and forecast by application
7.3.1. Europe Market size and forecast by end user

7.4. Asia-Pacific

7.4.1. Asia-Pacific market size and forecast, by product
7.4.2. Asia-Pacific market size and forecast, by application
7.4.3. Asia-Pacific market size and forecast, by end user

7.5. LAMEA

7.5.1. LAMEA Market size and forecast by product
7.5.1. LAMEA Market size and forecast by application
7.5.1. LAMEA Market size and forecast by end user

CHAPTER 8: COMPANY PROFILES

8.1. Alliqua BioMedical Inc.

8.1.1. Company overview
8.1.2. Company snapshot
8.1.3. Business performance
8.1.4. Key strategic moves and developments

8.2. Amnio Technology, LLC

8.2.1. Company overview
8.2.2. Company snapshot
8.2.3. Key strategic moves and developments

8.3. Applied Biologics LLC

8.3.1. Company overview
8.3.2. Company snapshot

8.4. FzioMed Inc.

8.4.1. Company overview
8.4.2. Company snapshot

8.5. Human Regenerative Technologies, LLC

8.5.1. Company overview
8.5.2. Company snapshot

8.6. Integra Lifesciences Holdings Corporation (Derma Sciences Inc.)

8.6.1. Company overview
8.6.2. Company snapshot
8.6.3. Operating business segments
8.6.4. Business performance
8.6.5. Key strategic moves and developments

8.7. Katena Products, Inc. (IOP Ophthalmics)

8.7.1. Company overview
8.7.2. Company snapshot

8.8. MiMedx Group Inc.

8.8.1. Company overview
8.8.2. Company snapshot
8.8.3. Operating business segments
8.8.4. Business performance

8.9. Skye Biologics Inc.

8.9.1. Company overview
8.9.2. Company snapshot
8.9.3. Key strategic moves and developments

8.10. Tissue-Tech Inc. (Amniox Medical Inc.)

8.10.1. Company overview
8.10.2. Company snapshot
8.10.3. Key strategic moves and developments